NICE, France, April 11, 2011 /PRNewswire/ — Mauna Kea
Technologies today announced highlights from the 3rd Annual
International Conference of Cellvizio® Users (ICCU). The
meeting included 32 different speakers and 25 posters on the role
and impact of probe-based confocal laser endomicroscopy (pCLE) with
Cellvizio in diagnosing, treating and managing patients with
gastrointestinal (GI) and lung diseases.
Cellvizio provides physicians with a cellular-level view of
living tissue inside the body during standard endoscopy exams. Over
95 experts from 12 countries and a variety of specialties,
including digestive and pulmonary endoscopy, urology, pathology and
image processing, attended the meeting, which was held in Nice,
France from April 8-10.
“Mounting evidence and clinical experience show that pCLE will
change the way disease is diagnosed and treatment decided upon,”
said ICCU 2011 co-chair Jean-Paul Galmiche, MD, FRCP, Professor of
Medicine, Nantes University Hospital, Nantes, France. “ICCU
provided an ideal forum for pCLE users to discuss new findings and
draw conclusions regarding how to accurately interpret Cellvizio
images, integrate the technology into our practices and manage
patients more effectively.”
The program for this conference was designed for Cellvizio users
to build on the knowledge physicians have obtained from current
clinical practice, discuss new major study results and build
consensus on image interpretation and best practices.
Attendees participated in the largest interactive pCLE image
interpretation workshop to date, as well as a hands-on workshop and
live demonstrations at the Princess Grace Hospital in Monaco.
“The community of pCLE users is working together to increase its
understanding and advance the science of this important
visualization tool in clinical applications where we require
faster, and more accurate diagnosis,” said ICCU 2011 co-chair
Prateek Sharma, MD, Professor of Medicine,